Install
FirstWord
- 112articles · 30d
- 19+ hour agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 13avg words
- Medical 92
- Health 75
- Health & Wellness 68
- Business & Industrial 39
- Economy, Business & Finance 25
- Finance & Business 16
- Science & Technology 10
- News 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
NodThera rebrands as Rezera, charts registrational path for PAD drug
4+ day, 11+ hour ago (12+ words) FirstWord Pharma...
Schr??dinger forms I&I-focused newco with NEA, RA Capital
4+ day, 16+ hour ago (11+ words) Schrödinger forms I&I-focused newco with NEA, RA Capital FirstWord PHARMA...
TwoStep's take on targeting solid tumours gains backing from Merck KGaA, Pfizer venture arms
5+ day, 1+ hour ago (16+ words) FirstWord Pharma...
Solstice raises $225M to advance next-gen CTLA-4 immunotherapy
5+ day, 21+ min ago (10+ words) FirstWord Pharma...
Pharvaris' oral HAE hopeful significantly cuts attacks in pivotal study
5+ day, 23+ hour ago (12+ words) FirstWord PHARMA...
Clover posts upbeat mid-stage data for respiratory vaccine combos
1+ week, 10+ hour ago (11+ words) FirstWord Pharma...
Physician Views Preview: Is Ionis' Dawnzera making its mark on HAE prophylaxis?
1+ week, 4+ day ago (14+ words) FirstWord Pharma...
uniQure submits long-awaited filing for Huntington's gene therapy
1+ week, 5+ day ago (10+ words) FirstWord Pharma...
Novartis chooses Alteogen tech for subcutaneous drug ambitions
1+ week, 5+ day ago (10+ words) FirstWord Pharma...
Novartis' Rhapsido delivers dual Phase III wins in relapsing MS
1+ week, 6+ day ago (11+ words) firstwordpharma.com...